
Macfos (ROBU) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
592.7M
Gross Profit
142.5M
24.04%
Operating Income
66.3M
11.19%
Net Income
50.4M
8.50%
EPS (Diluted)
₹5.35
Balance Sheet Metrics
Total Assets
1.1B
Total Liabilities
376.7M
Shareholders Equity
702.3M
Debt to Equity
0.54
Cash Flow Metrics
Revenue & Profitability Trend
Macfos Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 2.6B | 1.3B | 801.7M | 555.1M | 271.2M |
Cost of Goods Sold | 2.1B | 939.3M | 583.8M | 385.1M | 183.9M |
Gross Profit | 476.0M | 312.1M | 217.9M | 170.1M | 87.2M |
Gross Margin % | 18.7% | 24.9% | 27.2% | 30.6% | 32.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 61.3M | 40.8M | 34.1M | 25.8M |
Other Operating Expenses | 141.9M | 20.8M | 13.5M | 12.1M | 2.7M |
Total Operating Expenses | 141.9M | 82.1M | 54.3M | 46.1M | 28.5M |
Operating Income | 235.6M | 148.9M | 104.6M | 84.3M | 30.4M |
Operating Margin % | 9.2% | 11.9% | 13.1% | 15.2% | 11.2% |
Non-Operating Items | |||||
Interest Income | - | 2.1M | 437.0K | 410.0K | 105.0K |
Interest Expense | 22.4M | 13.6M | 9.7M | 6.8M | 4.4M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 240.2M | 147.3M | 100.5M | 79.5M | 21.2M |
Income Tax | 61.0M | 39.0M | 26.4M | 20.5M | 5.4M |
Effective Tax Rate % | 25.4% | 26.5% | 26.3% | 25.7% | 25.3% |
Net Income | 179.2M | 108.3M | 74.1M | 59.0M | 15.8M |
Net Margin % | 7.0% | 8.7% | 9.2% | 10.6% | 5.8% |
Key Metrics | |||||
EBITDA | 271.3M | 167.7M | 115.1M | 90.3M | 35.7M |
EPS (Basic) | ₹19.14 | ₹12.25 | ₹8.39 | ₹6.68 | ₹1.79 |
EPS (Diluted) | ₹19.14 | ₹12.25 | ₹8.39 | ₹6.68 | ₹1.79 |
Basic Shares Outstanding | 9362278 | 8835424 | 8833611 | 8835424 | 8835424 |
Diluted Shares Outstanding | 9362278 | 8835424 | 8833611 | 8835424 | 8835424 |
Income Statement Trend
Macfos Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 5.1M | 6.8M | 11.3M | 8.6M | 6.4M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 57.2M | 34.8M | 24.3M | 17.3M | 8.7M |
Inventory | 556.0M | 243.9M | 166.4M | 118.5M | 52.9M |
Other Current Assets | 8.0M | 6.3M | 4.5M | 1.5M | 11.0K |
Total Current Assets | 839.2M | 381.5M | 261.8M | 184.9M | 83.2M |
Non-Current Assets | |||||
Property, Plant & Equipment | 100.0M | 57.6M | 2.0K | 1.0K | 1.0K |
Goodwill | 3.9M | 3.5M | 2.9M | 706.0K | 423.0K |
Intangible Assets | 3.9M | 3.5M | 2.9M | 706.0K | 423.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 131.7M | -1.0K | 3.0K | 1.0K | 2.0K |
Total Non-Current Assets | 239.9M | 120.1M | 67.0M | 19.5M | 11.0M |
Total Assets | 1.1B | 501.6M | 328.7M | 204.4M | 94.2M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 102.0M | 77.5M | 59.2M | 24.7M | 17.3M |
Short-term Debt | 186.3M | 59.8M | 24.3M | 28.8M | 31.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 4.2M | 1.0K | -2.0K | 7.0K | 52.0K |
Total Current Liabilities | 358.0M | 201.5M | 123.2M | 82.0M | 58.6M |
Non-Current Liabilities | |||||
Long-term Debt | 13.7M | 22.0M | 40.6M | 31.5M | 3.4M |
Deferred Tax Liabilities | 0 | - | - | 0 | 0 |
Other Non-Current Liabilities | 1.0K | 10.0K | - | 1.0K | -1.0K |
Total Non-Current Liabilities | 18.7M | 26.9M | 40.6M | 31.5M | 4.5M |
Total Liabilities | 376.7M | 228.4M | 163.8M | 113.5M | 63.1M |
Equity | |||||
Common Stock | 94.2M | 88.4M | 88.4M | 101.0K | 101.0K |
Retained Earnings | - | 184.5M | 76.3M | 80.5M | 20.7M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 702.3M | 273.2M | 165.0M | 90.8M | 31.1M |
Key Metrics | |||||
Total Debt | 200.1M | 81.8M | 64.8M | 60.3M | 35.0M |
Working Capital | 481.1M | 180.0M | 138.5M | 102.9M | 24.6M |
Balance Sheet Composition
Macfos Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 240.4M | 147.3M | 100.5M | 79.5M | 21.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -446.8M | -101.4M | -59.6M | -90.3M | -31.6M |
Operating Cash Flow | -191.1M | 57.7M | 51.8M | -3.0M | -5.3M |
Investing Activities | |||||
Capital Expenditures | -48.6M | -19.5M | -51.3M | -5.0M | -1.1M |
Acquisitions | - | - | 0 | 0 | - |
Investment Purchases | - | - | 0 | 0 | - |
Investment Sales | - | - | 0 | 0 | - |
Investing Cash Flow | -127.6M | -59.8M | -51.7M | -6.3M | -1.1M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 376.6M | 35.5M | -4.5M | -2.0M | 8.0M |
Free Cash Flow | -294.5M | 30.5M | 3.5M | -11.2M | 1.9M |
Net Change in Cash | 57.9M | 33.4M | -4.4M | -11.3M | 1.6M |
Cash Flow Trend
Macfos Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
36.24
Price to Book
9.72
Price to Sales
2.67
PEG Ratio
0.64
Profitability Ratios
Profit Margin
7.36%
Operating Margin
11.19%
Return on Equity
25.51%
Return on Assets
16.61%
Financial Health
Current Ratio
2.34
Debt to Equity
28.49
Beta
-0.28
Per Share Data
EPS (TTM)
₹20.13
Book Value per Share
₹75.06
Revenue per Share
₹273.53
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
robu | 6.9B | 36.24 | 9.72 | 25.51% | 7.36% | 28.49 |
PG Electroplast | 160.7B | 58.37 | 5.48 | 10.18% | 5.33% | 13.58 |
Syrma SGS Technology | 125.2B | 62.48 | 7.16 | 9.31% | 5.61% | 36.42 |
Centum Electronics | 35.3B | 1,237.16 | 8.71 | -0.49% | 0.91% | 47.52 |
Cyient DLM | 33.8B | 52.07 | 3.55 | 7.17% | 4.22% | 31.73 |
Ikio Lighting | 14.7B | 65.55 | 2.62 | 5.50% | 4.62% | 9.38 |
Financial data is updated regularly. All figures are in the company's reporting currency.